Abstract:Background: Depression is widely recognized as a common non-motor symptom of Parkinson's disease (PD). Across different studies, the reported prevalence of depression in PD varies widely, ranging from 2.7% to 90%, but it is unclear whether this association is due to genetic or acquired factors. Whether there is a causal relationship remains unknown. The aim of this study was to use a two-sample Mendelian randomization (MR) approach to investigate the causal effect of PD on depression. Methods: Analyses were conducted separately for individuals of European and East Asian ancestry using publicly available summary data from genome-wide association studies. Depression was divided into two categories: ever depressed for a whole week and major depressive disorder (MDD). PD data were used as the exposure and were obtained from the International Parkinson's Disease Genomics Consortium and the BioBank Japan PheWeb, while depression data were used as the outcome and were obtained from the ntegrative Epidemiology Unit (IEU) Open GWAS Project(A public GWAS database） and the Psychiatric Genomics Consortium. The influence of PD on depression was assessed using inverse variance weighted (IVW), weighted median, MR-Egger, and weighted mode methods. Heterogeneity and pleiotropy were tested, and the results were validated using FinnGen GWAS data from version R9. Results: In individuals of European ancestry, there was a causal relationship between PD and ever depressed for a whole week (IVW method, odds ratio [OR] = 0.990; 95% CI, 0.984-0.996; p = .002), but no causal relationship was observed between PD and MDD (IVW method, OR = 0.974; 95% CI, 0.942-1.009; p = .141). In individuals of East Asian ancestry, no causal relationship was observed between PD and ever depressed for a whole week (IVW method, OR = 1.001; 95% CI, 0.829-1.209; p = .990) and between PD and MDD (IVW method, OR = 1.017; 95% CI, 0.982-1.052; p = .342). The results of the three additional analysis methods were similar to those of the IVW method, and there was no heterogeneity according to Cochran's Q-test. There was no evidence of pleiotropy based on MR-Egger intercept test and MR-PRESSO. The FinnGen validation dataset supported these findings. The results are stable and reliable. Conclusion: The observed increase in depression among PD patients could potentially be attributed to modifiable acquired factors. Consequently, there is an urgent need to strengthen the management of PD patients in order to prevent the development of depression in the future.

Investigating the Shared Genetic Etiology Between Parkinson's Disease and Depression

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson's Disease

Identification and Experimental Validation of Parkinson’s Disease with Major Depressive Disorder Common Genes

Risk of Parkinson's disease and depression severity in different populations: A two-sample Mendelian randomization analysis

Association Between Gene Polymorphism and Depression in Parkinson's Disease: A Case-Control Study

Discovering genetic mechanisms underlying the co-occurrence of Parkinson’s disease and non-motor traits

Shared Polygenic Risk and Causal Inferences in Parkinson's Disease

Shared Genetic Architecture between Parkinson's Disease and Brain Structural Phenotypes

Investigating the Shared Genetic Architecture Between Psychiatric Disorders and Executive Function

Immune system disruptions implicated in whole blood epigenome-wide association study of depression among Parkinson's disease patients

Shared Genetic Background between Parkinson's Disease and Schizophrenia: A Two-Sample Mendelian Randomization Study

Investigating the shared genetic architecture between depression and subcortical volumes

Gene–environment Interactions: Key to Unraveling the Mystery of Parkinson's Disease

Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)

Genetic Evidence Supporting a Causal Role of Depression in Alzheimer's Disease

Shared mechanisms across the major psychiatric and neurodegenerative diseases

Gene-Environment Interactions for Parkinson's Disease

Exploring the shared genetic basis of major depressive disorder and frailty

Parkinson’s Disease-Associated Genetic Variants Synergistically Shape Brain Networks

Bioinformatic Analysis of Genetic Factors from Human Blood Samples and Postmortem Brains in Parkinson's Disease

The Influence of Depression in the Evolution of Parkinson's Disease: A Psychiatric Perspective